πŸ‡ΊπŸ‡Έ FDA
Patent

US 8436043

Heterocyclic compound

granted A61PA61P3/08A61P3/10

Quick answer

US patent 8436043 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P3/08, A61P3/10, A61P43/00